Trial · NCT00083122
Adverse events92
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 92
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hemoglobin decreased | Blood and lymphatic system disorders | Group 1 and Group 2 Combined | 42 | 45 | 179 |
| other | Palpitations | Cardiac disorders | Group 1 and Group 2 Combined | 2 | 45 | 2 |
| other | Hearing impaired | Ear and labyrinth disorders | Group 1 and Group 2 Combined | 2 | 45 | 3 |
| other | Hearing test abnormal | Ear and labyrinth disorders | Group 1 and Group 2 Combined | 1 | 45 | 1 |
| other | Tinnitus | Ear and labyrinth disorders | Group 1 and Group 2 Combined | 3 | 45 | 15 |
| other | Abdominal pain | Gastrointestinal disorders | Group 1 and Group 2 Combined | 1 | 45 | 1 |
| other | Colitis | Gastrointestinal disorders | Group 1 and Group 2 Combined | 1 | 45 | 1 |
| other | Constipation | Gastrointestinal disorders | Group 1 and Group 2 Combined | 3 | 45 | 7 |
| other | Diarrhea | Gastrointestinal disorders | Group 1 and Group 2 Combined | 31 | 45 | 123 |
| other | Dry mouth | Gastrointestinal disorders | Group 1 and Group 2 Combined | 1 | 45 | 2 |
| other | Dyspepsia | Gastrointestinal disorders | Group 1 and Group 2 Combined | 2 | 45 | 4 |
| other | Ear, nose and throat examination abnormal | Gastrointestinal disorders | Group 1 and Group 2 Combined | 1 | 45 | 1 |
| other | Gastritis | Gastrointestinal disorders | Group 1 and Group 2 Combined | 1 | 45 | 5 |
| other | Mucositis oral | Gastrointestinal disorders | Group 1 and Group 2 Combined | 5 | 45 | 5 |
| other | Nausea | Gastrointestinal disorders | Group 1 and Group 2 Combined | 42 | 45 | 153 |
| other | Vomiting | Gastrointestinal disorders | Group 1 and Group 2 Combined | 32 | 45 | 93 |
| other | Fatigue | General disorders | Group 1 and Group 2 Combined | 44 | 45 | 165 |
| other | Pain | General disorders | Group 1 and Group 2 Combined | 2 | 45 | 7 |
| other | Urinary tract infection | Infections and infestations | Group 1 and Group 2 Combined | 1 | 45 | 1 |
| other | Vascular access complication | Injury, poisoning and procedural complications | Group 1 and Group 2 Combined | 1 | 45 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00083122/events